Treatment of Epilepsy with Myoclonic-Atonic Seizures in Children Younger Than 16 Years
This protocol addresses the treatment of epilepsy with myoclonic-atonic seizures specifically in children younger than 16 years — a clinical population defined by both the patient's age and the characteristic seizure pattern.
The seizure pattern is defined by a myoclonic seizure that occurs and is followed by an atonic seizure. This sequence, in a child younger than 16 years, constitutes the population this protocol is designed for.
Management begins with a monotherapy approach using an antiepileptic drug indicated for this seizure type in children. The choice of medication is guided by the specific seizure pattern. The full selection criteria, titration schedule, and dosing details are available in the complete protocol.
The therapeutic objective is reduction or elimination of seizures, with the primary aim being seizure freedom.
- Myoclonic seizure occurs, followed by an atonic seizure
- Children (younger than 16 years)
- Treatment should begin with monotherapy.
- The appropriate choice of medication varies depending on seizure type.
- When patients have been seizure free for two to five years, discontinuation of antiepileptic drugs may be considered.